BIOLINERX
Careers | Contact Us
search

Drugs in Developement

BL-8040

Indication: Solid tumors, malignant and non-malignant hematological indications
Mode of Action: CXCR4 antagonism
Stage of development: Phase 2
Patent Status: Over 10 patent families cover the composition and methods of use, patents granted or pending worldwide.